Yuki Ozaki

751 total citations
40 papers, 483 citations indexed

About

Yuki Ozaki is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Yuki Ozaki has authored 40 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Physiology. Recurrent topics in Yuki Ozaki's work include Alzheimer's disease research and treatments (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Lung Cancer Treatments and Mutations (6 papers). Yuki Ozaki is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Lung Cancer Treatments and Mutations (6 papers). Yuki Ozaki collaborates with scholars based in Japan. Yuki Ozaki's co-authors include Shuichi Ueno, Jun‐ichi Iga, Kiyohiro Yamazaki, Yuta Yoshino, Shinichiro Ochi, Takaaki Mori, Tomoko Sao, Taku Yoshida, Yoko Mori and Yoko Mori and has published in prestigious journals such as Scientific Reports, International Journal of Heat and Mass Transfer and Psychiatry Research.

In The Last Decade

Yuki Ozaki

38 papers receiving 477 citations

Peers

Yuki Ozaki

PHYSI

NEURO

ONCOL

PRM

Ayesha P. Ng United States

Caterina Carbonell Spain

I. Carrero Spain

Satoru Tada Japan

Yingxue Ren United States

Lili Mo China

Yanqing Kan United States

Rayshad Gopaul Canada

Erica J. Lawson United States

Maohong Cao China

Ayesha P. Ng United States

Yuki Ozaki

217 ×1.2

153 ×1.0

PHYSI

265 ×2.6

NEURO

45 ×0.5

ONCOL

50 ×0.8

PRM

Citations per year, relative to Yuki Ozaki Yuki Ozaki (= 1×) peers Ayesha P. Ng

Countries citing papers authored by Yuki Ozaki

Since Specialization

Citations

This map shows the geographic impact of Yuki Ozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Ozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Ozaki more than expected).

Fields of papers citing papers by Yuki Ozaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Ozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Ozaki. The network helps show where Yuki Ozaki may publish in the future.

Co-authorship network of co-authors of Yuki Ozaki

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Ozaki. A scholar is included among the top collaborators of Yuki Ozaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Ozaki. Yuki Ozaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Muto, Satoshi, Yuki Ozaki, Hikaru Yamaguchi, et al.. (2025). Tumor β-Catenin Expression Associated With Poor Prognosis to Anti-PD-1 Antibody Monotherapy in Non-small Cell Lung Cancer. Cancer Diagnosis & Prognosis. 5(1). 32–41. 1 indexed citations

Iga, Jun‐ichi, Yuta Yoshino, Hiroaki Mori, et al.. (2024). Blood RNA transcripts show changes in inflammation and lipid metabolism in Alzheimer's disease and mitochondrial function in mild cognitive impairment. Journal of Alzheimer s Disease Reports. 8(1). 1690–1703. 1 indexed citations

Yoshida, Taku, Takaaki Mori, Hideaki Shimizu, et al.. (2023). Analysis of factors related to cognitive impairment in a community‐based, complete enumeration survey in Japan: the Nakayama study. Psychogeriatrics. 23(5). 876–884. 3 indexed citations

Yoshino, Yuta, Hiroaki Mori, Mariko Ueno, et al.. (2023). Gestational exposure to haloperidol changes Cdkn1a and Apaf1 mRNA expressions in mouse hippocampus. Brain Research Bulletin. 199. 110662–110662. 1 indexed citations

Matsumura, Yuki, Mitsuro Fukuhara, Hikaru Yamaguchi, et al.. (2022). Thoracoscopic resection of posterior mediastinal paraganglioma: perioperative management and surgical tips. Journal of Cardiothoracic Surgery. 17(1). 143–143. 2 indexed citations

Watanabe, Masayuki, Yuki Matsumura, Hikaru Yamaguchi, et al.. (2022). Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report. Thoracic Cancer. 13(19). 2817–2822. 1 indexed citations

Matsumura, Yuki, Yasuyuki Kobayashi, Hikaru Yamaguchi, et al.. (2022). Lung adenocarcinoma coexisting with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia manifesting as multiple pulmonary nodules: A case report. Thoracic Cancer. 13(21). 3076–3079. 3 indexed citations

Takagi, Hironori, Satoshi Muto, Hikaru Yamaguchi, et al.. (2021). Our experience of lung resection in patients who decline blood transfusion for religious reasons. General Thoracic and Cardiovascular Surgery. 69(7). 1105–1111. 2 indexed citations

Muto, Satoshi, Yuki Ozaki, Takuya Inoue, et al.. (2021). Diffuse Cystic Metastases in the Lung after Nivolumab Treatment in a Patient with Non-Small Cell Lung Cancer: A Case Report. Case Reports in Oncology. 14(1). 34–38.

10.

Muto, Satoshi, Hikaru Yamaguchi, Hironori Takagi, et al.. (2021). CTLA-4 Expression in Tumor-infiltrating Lymphocytes Is Irrelevant to PD-L1 Expression in NSCLC. Anticancer Research. 41(12). 6267–6272.

11.

Watanabe, Masayuki, Tomohito Higashi, Atsuko Y. Higashi, et al.. (2021). CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma. Scientific Reports. 11(1). 12554–12554. 16 indexed citations

12.

Yamazaki, Kiyohiro, Yuta Yoshino, Kentaro Kawabe, et al.. (2020). <p>ABCA7 Gene Expression and Genetic Association Study in Schizophrenia</p>. Neuropsychiatric Disease and Treatment. Volume 16. 441–446. 3 indexed citations

13.

Yoshino, Yuta, Hiroaki Mori, Mariko Ueno, et al.. (2020). PICALM mRNA Expression in the Blood of Patients with Neurodegenerative Diseases and Geriatric Depression. Journal of Alzheimer s Disease. 79(3). 1055–1062. 17 indexed citations

14.

Miyamoto, Keisuke, Yuta Yoshino, Kentaro Kawabe, et al.. (2020). CTLA4 mRNA expression in blood is lower in schizophrenia, but not in affective disorders. Asian Journal of Psychiatry. 52. 102112–102112. 5 indexed citations

15.

Ozaki, Yuki, Satoshi Muto, Hironori Takagi, et al.. (2019). Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer. Cancer Immunology Immunotherapy. 69(1). 127–134. 36 indexed citations

16.

Nakata, Shunsuke, Yuta Yoshino, Kentaro Kawabe, et al.. (2018). Differential expression of the ghrelin-related mRNAs GHS-R1a, GHS-R1b, and MBOAT4 in Japanese patients with schizophrenia. Psychiatry Research. 272. 334–339. 9 indexed citations

17.

Yoshino, Yuta, Shunsuke Nakata, Yuki Ozaki, et al.. (2018). Ghrelin cascade changes in the peripheral blood of Japanese patients with Alzheimer's disease. Journal of Psychiatric Research. 107. 79–85. 12 indexed citations

18.

Ozaki, Yuki, Yuta Yoshino, Kiyohiro Yamazaki, et al.. (2017). DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease. Journal of Psychiatric Research. 92. 74–80. 68 indexed citations

19.

Sao, Tomoko, Yuta Yoshino, Kiyohiro Yamazaki, et al.. (2017). MEF2C mRNA expression and cognitive function in Japanese patients with Alzheimer's disease. Psychiatry and Clinical Neurosciences. 72(3). 160–167. 34 indexed citations

20.

Yamazaki, Kiyohiro, Yuta Yoshino, Takaaki Mori, et al.. (2016). Association Study and Meta-Analysis of Polymorphisms, Methylation Profiles, and Peripheral mRNA Expression of the Serotonin Transporter Gene in Patients with Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders. 41(5-6). 334–347. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact